©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1051-1058
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1051
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1051
Table 2 Synchronous superficial head and neck squamous cell carcinoma lesions n (%)
| Group A (n = 254) | Group B (n = 307) | P value | |
| Synchronous HNSCC | |||
| No. of patients | 1 (0.3) | 12 (3.9) | 0.008 |
| No. of lesions | 1 | 14 | 0.010 |
| Location of cancer | |||
| Oropharynx | 0 | 5 | |
| Hypopharynx | 1 | 8 | |
| Larynx | 0 | 1 | |
| Treatment for synchronous HNSCC | |||
| ER or surgical local resection | 0 | 7 (58) | |
| TPLE | 0 | 1 (8) | |
| Radiation and/or chemotherapy | 1 (100) | 0 | |
| No treatment | 0 | 4 (33) | |
| Death due to synchronous HNSCC | 0 | 0 |
- Citation: Morimoto H, Yano T, Yoda Y, Oono Y, Ikematsu H, Hayashi R, Ohtsu A, Kaneko K. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(6): 1051-1058
- URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1051.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i6.1051